Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switching From Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention (TAILOR-BLEED-2)

NCT07025148 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT07025148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07025148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switching From Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention (TAILOR-BLEED-2)
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2025
Completion date
November 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad), percutaneous coronary intervention (pci)